Adeno-associated virus (AAV) vectors achieve prolonged transgene expression in mouse myocardium and arteries in vivo: a comparative study with adenovirus vectors
- 1 August 2003
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 90 (2-3) , 229-238
- https://doi.org/10.1016/s0167-5273(02)00554-5
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Myocardial Doppler tissue velocity improves following myocardial gene therapy with VEGF-A165 plasmid in patients with inoperable angina pectorisCoronary Artery Disease, 2001
- Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapyJournal of the American College of Cardiology, 2000
- Catheter-Mediated Vascular Endothelial Growth Factor Gene Transfer to Human Coronary Arteries after AngioplastyHuman Gene Therapy, 2000
- Cardiovascular gene therapyThe Lancet, 2000
- Percutaneous Myocardial Gene Transfer of phVEGF-2Circulation, 1999
- Six-Month Assessment of a Phase I Trial of Angiogenic Gene Therapy for the Treatment of Coronary Artery Disease Using Direct Intramyocardial Administration of an Adenovirus Vector Expressing the VEGF121 cDNAAnnals of Surgery, 1999
- Gene Therapy for Myocardial AngiogenesisCirculation, 1998
- Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb IschemiaCirculation, 1998
- Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limbThe Lancet, 1996
- Expression of recombinant genes in myocardium in vivo after direct injection of DNA.Circulation, 1990